Company Overview of University of Birmingham
A U.K. university, is active in life science research and technology transfer to the private sector
Birmingham, B15 2TT
Founded in 1900
Key Executives for University of Birmingham
University of Birmingham does not have any Key Executives recorded.
University of Birmingham Key Developments
Cancer Research Technology, Birmingham University and Alta Innovations Collaborate to Commercialize Cancer Research
Aug 9 16
Cancer Research Technology (CRT) has signed an agreement with the University of Birmingham and its commercial division Alta Innovations (Alta) to work in collaboration to develop and commercialise the university’s cancer research. The two-year agreement is focused on speeding up commercialisation of the University of Birmingham’s major cancer research into diagnostics, treatments and technologies that can benefit patients. Under the deal, Alta will work in close cooperation with the scientists at the university with an aim to recognise most promising cancer research opportunities. CRT, on the other hand, will use its expertise to commercialise cancer research and its vast network across the pharmaceutical and biotechnology industry in order to identify and translate promising research at the university. CRT will work with Alta and the University of Birmingham’s academics in a bid to promising cancer opportunities, along with the major clinical expertise available and the university’s primary research in areas such as immunology and genomics. The financial benefits received from the research will be shared between CRT and the University of Birmingham. CRT will use its financial returns to invest in Cancer Research UK’s life-saving research, while the University of Birmingham will be used for the benefit of the educational charity.
The University of Birmingham and Nankai University Agree Research and Teaching Collaboration
Jun 17 16
The University of Birmingham and Nankai University have signed a formal agreement to work together on research and teaching. The partnership strengthens existing collaboration between the two universities, which have committed to exploring research areas of common strength and interest. Academics from the two universities will now discuss working together across a range of research areas as diverse as environmental sciences, mathematics, biosciences and computational biology. They will also develop Nankai students' participation in Birmingham's 'Study Abroad' programme, which will see students spending two years at each university. A delegation from the university, which is based in the Chinese city of Tianjin, made a special visit to sign the new agreement in a ceremony on the Edgbaston campus.
Thermo Fisher Scientific, Inc. to Extend Technology Collaboration with University of Birmingham
May 31 16
Thermo Fisher Scientific Inc. has announced plans to extend its technology collaboration with the University of Birmingham in the UK at the University's new Phenome Centre. Thermo Fisher will supply a range of advanced mass spectrometry instruments to be used for the centre's research in metabolic phenotyping and metabolomics studies. In collaboration with Birmingham Health Partners, the Phenome Centre Birmingham is an GBP8M facility that aims to provide University of Birmingham scientists with the tools needed to conduct large-scale metabolic phenotyping research. The centre's goal is to better understand biochemical mechanisms, targets and biomarkers associated with aging and disease, to enable a stratified medicine approach that will enhance patient outcomes. The new facility is equipped with a range of instruments for untargeted and targeted assays including the Thermo Scientific Q Exactive Focus Hybrid Quadrupole-Orbitrap, TSQ Quantiva Triple Quadrupole and Orbitrap Elite Hybrid Ion Trap-Orbitrap mass spectrometers, each equipped with a Thermo Scientific liquid chromatography system. In addition, a Q Exactive Plus Hybrid Quadrupole-Orbitrap mass spectrometer will be used for training purposes in the Birmingham Metabolomics Training Centre. Thermo Fisher provided the University of Birmingham with prototype technology for evaluation, supported several PhD students on metabolomics related research projects and collaborated with the Phenome Centre Birmingham in the Metabolomics Training Centre.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries